SHP1/SHP2 activity and the expression level of SIRPα were also significantly reduced in TAM-treated GH3 and AtT-20 cells as well as tumor tissues of mice (Figure 9C–E and Figure S5C–E). This evidence concerns the gene PTPN11 and neoplasm.